10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2011 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 97,688 | 94,503 | 93,568 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (75,148) | (73,143) | (73,536) |
| Cash paid to other suppliers and employees | (13,635) | (13,778) | (13,121) |
| Interest received | 4 | 4 | 5 |
| Interest paid | (647) | (583) | (542) |
| Income taxes paid | (2,406) | (2,224) | (2,339) |
| Net cash provided by operating activities | 5,856 | 4,779 | 4,035 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,872) | (2,005) | (2,548) |
| Proceeds from sale-leaseback transactions | 592 | 507 | 1,562 |
| Proceeds from sale of property and equipment | 4 | 34 | 23 |
| Acquisitions (net of cash acquired) and other investments | (1,441) | (177) | (101) |
| Purchase of available-for-sale investments | (3) | (5) | |
| Sale or maturity of available-for-sale investments | 60 | 1 | |
| Proceeds from sale of subsidiary | 250 | ||
| Net cash used in investing activities | (2,410) | (1,640) | (1,069) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 450 | (15) | (2,729) |
| Proceeds from issuance of long-term debt | 1,463 | 991 | 2,800 |
| Repayments of long-term debt | (2,122) | (2,103) | (653) |
| Dividends paid | (674) | (479) | (439) |
| Derivative settlements | (19) | (5) | (3) |
| Proceeds from exercise of stock options | 431 | 285 | 250 |
| Excess tax benefits from stock-based compensation | 21 | 28 | 19 |
| Repurchase of common stock | (3,001) | (1,500) | (2,477) |
| Other | (9) | ||
| Net cash used in financing activities | (3,460) | (2,798) | (3,232) |
| Net increase (decrease) in cash and cash equivalents | (14) | 341 | (266) |
| Cash and cash equivalents at the beginning of the year | 1,427 | 1,086 | |
| Cash and cash equivalents at the end of the year | 1,413 | 1,427 | 1,086 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 3,457 | 3,424 | 3,696 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,568 | 1,469 | 1,389 |
| Stock-based compensation | 135 | 150 | 165 |
| Gain on sale of subsidiary | (53) | ||
| Deferred income taxes and other noncash items | 144 | 30 | 48 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (748) | 532 | (86) |
| Inventories | 607 | (352) | (1,199) |
| Other current assets | (420) | (4) | 48 |
| Other assets | (49) | (210) | (2) |
| Accounts payable | 1,128 | (40) | 4 |
| Accrued expenses | 85 | (176) | (66) |
| Other long-term liabilities | 2 | (44) | 38 |
| Net cash provided by operating activities | 5,856 | 4,779 | 4,035 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |